Press Releases

Oct 27, 2020
SAN DIEGO --(BUSINESS WIRE)--Oct. 27, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020 . Third Quarter 2020 Financial Highlights:   Revenue grew 26% versus the same quarter of the prior year to $500.9 million U.S.
Oct 13, 2020
SAN DIEGO --(BUSINESS WIRE)--Oct. 13, 2020-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Kyle Malady to its Board of Directors, effective immediately. Mr. Malady currently serves as executive vice president of global
Sep 04, 2020
SAN DIEGO --(BUSINESS WIRE)--Sep. 4, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences: Steve Pacelli , Executive Vice President Strategy and Corporate Development, and Jereme Sylvain , Senior
Aug 12, 2020
SAN DIEGO --(BUSINESS WIRE)--Aug. 12, 2020-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Karen Dahut to its Board of Directors, effective immediately. Ms. Dahut has more than 25 years of leadership experience in
Aug 10, 2020
SAN DIEGO --(BUSINESS WIRE)--Aug. 10, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Quentin Blackford , Chief Operating Officer and Chief Financial Officer, and Steve Pacelli , Executive Vice
Jul 28, 2020
SAN DIEGO --(BUSINESS WIRE)--Jul. 28, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2020 . Second Quarter 2020 Financial Highlights: Revenue grew 34% versus the same quarter of the prior year to $451.8 million U.S.
Displaying 1 - 10 of 26